Photo-Acoustic and Ultrasonographic Mammoscope
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18+
SponsorFranciscus Gasthuis & Vlietland (Hospital)
About this trial
The aim of this study is to evaluate the negative predictive value of the Photo Acoustic Imager 3+ (PAM3+) in the detection of female breast lesions (malignant and benign)in an outpatient setting.
Eligibility criteria
Qualifiers
Women
Age > 18 years
Referred to the outpatient breast clinic of the Franciscus Vlietland Hospital due to a possible breast lesion
Patients who are fully competent to give written informed consent
Disqualifiers
Currently undergoing chemotherapy
Discharge from the nipple(s)
Breast ulcers or -wounds
Currently suffering from mastitis
Trial design
Treatments tested in this trial
- Photo-Acoustic Mammoscope Imager 3+
Treatment groups
180 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov